Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review.
Yang, Chenghao
Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review. [electronic resource] - Journal of affective disorders 10 2019 - 640-649 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
1573-2517
10.1016/j.jad.2019.07.045 doi
Adult
Antidepressive Agents--therapeutic use
Biomarkers--blood
C-Reactive Protein--analysis
Depressive Disorder, Treatment-Resistant--blood
Female
Humans
Inflammation Mediators--blood
Infliximab--therapeutic use
Interferon-gamma--blood
Interleukin-6--blood
Ketamine--therapeutic use
Male
Middle Aged
Treatment Outcome
Tumor Necrosis Factor-alpha--blood
Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review. [electronic resource] - Journal of affective disorders 10 2019 - 640-649 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
1573-2517
10.1016/j.jad.2019.07.045 doi
Adult
Antidepressive Agents--therapeutic use
Biomarkers--blood
C-Reactive Protein--analysis
Depressive Disorder, Treatment-Resistant--blood
Female
Humans
Inflammation Mediators--blood
Infliximab--therapeutic use
Interferon-gamma--blood
Interleukin-6--blood
Ketamine--therapeutic use
Male
Middle Aged
Treatment Outcome
Tumor Necrosis Factor-alpha--blood